New technology sends antibodies through blood-brain barrier
The results of the Roche-designed Brain Shuttle technology, a means of efficiently transferring investigational antibodies from the blood through the blood-brain barrier into the brain, may be big news in the fight against Alzheimer’s. By transferring antibodies through the barrier, scientists were able to reduce amyloids in a mouse’s brain.
www.sciencedaily.com/releases/2014/01/140108123537.htm
Related Posts
-
Pets may be linked to slower cognitive decline
Posted on Mar 24, 2022
-
Poor score on simple memory test may be linked to Alzheimer’s biomarkers
Posted on Mar 15, 2022
-
Hypertension in young adults affects brain later
Posted on Mar 8, 2022
-
Being lonely more often may raise dementia risk
Posted on Mar 3, 2022
Tags
Share This
